Literature DB >> 3942535

Susceptibility of Acanthamoeba to cryotherapeutic method.

D M Meisler, I H Ludwig, I Rutherford, F E Bican, R H Langston, G S Visvesvara.   

Abstract

Acanthamoeba keratitis is becoming an increasingly well-known clinical entity. The Acanthamoeba species in their encysted state are resistant to antimicrobial agents, resulting in corneal infections that are refractory to medical therapy. Corneal cryotherapy has been used to treat Acanthamoeba keratitis with varying and equivocal success. We subjected trophozoites and cysts of two species of Acanthamoeba recovered from corneal infections to trials of in vitro freeze-thaw-refreeze cryotherapeutic methods. The trophozoites of both species were killed in all trials. However, the cysts of both species survived all trials. Cryotherapy may not be an effective means to eliminate Acanthamoeba cysts from the cornea.

Entities:  

Mesh:

Year:  1986        PMID: 3942535     DOI: 10.1001/archopht.1986.01050130144040

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  Screening of the in vitro amoebicidal activities of Pastinaca armenea (Fisch. & C.A.Mey.) and Inula oculus-christi (L.) on Acanthamoeba castellanii cysts and trophozoites.

Authors:  Serpil Degerli; Seyda Berk; Erdogan Malatyali; Bektas Tepe
Journal:  Parasitol Res       Date:  2011-07-07       Impact factor: 2.289

2.  Excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay for recalcitrant filamentary fungal keratitis: A retrospective comparative clinical data analysis.

Authors:  Yingxin Chen; Minghong Gao; Joshua K Duncan; Di Ran; Denise J Roe; Michael W Belin; Mingwu Wang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

3.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

4.  In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.

Authors:  Zubeyde Akin Polat; Bektas Tepe; Ayse Vural
Journal:  Parasitol Res       Date:  2007-07-30       Impact factor: 2.289

5.  Acanthamoeba sclerokeratitis.

Authors:  Katayoon B Ebrahimi; W Richard Green; Rhonda Grebe; Albert S Jun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-09       Impact factor: 3.117

6.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

Review 7.  Update on diagnosis and management of refractory corneal infections.

Authors:  Shweta Agarwal; Tanveer A Khan; Murugesan Vanathi; Bhaskar Srinivasan; Geetha Iyer; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.